AXSOME THERAPEUTICS INC. - COMMON STOCK

132.20

11-February-25 16:45:00

15 minutes delayed

Stocks

+5.12

+4.03%

Today's range

128.00 - 134.19

ISIN

N/A

Source

NASDAQ

Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

10 May 2021 07:00:00 By Nasdaq GlobeNewswire
Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health Month

07 May 2021 07:00:00 By Nasdaq GlobeNewswire
Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021

27 Apr 2021 07:00:01 By Nasdaq GlobeNewswire
Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder

26 Apr 2021 06:00:00 By Nasdaq GlobeNewswire
Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

01 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
Axsome Therapeutics to Present at Upcoming Investor Conferences

19 Feb 2021 07:00:00 By Nasdaq GlobeNewswire
Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021

16 Feb 2021 07:00:02 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.